华海药业：约4115.23万股限售股9月25日解禁

Group 1 - Company Huahai Pharmaceutical announced that approximately 41.15 million restricted shares will be unlocked and listed for trading on September 25, 2025, accounting for about 2.75% of the company's total share capital [1] - For the year 2024, the revenue composition of Huahai Pharmaceutical is as follows: finished drug sales account for 60.32%, raw materials and intermediates sales account for 38.19%, technical services account for 0.66%, other businesses account for 0.55%, and other industries account for 0.28% [1] - The current market capitalization of Huahai Pharmaceutical is 34.4 billion yuan [2]